14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
Employers recently received a favorable ruling when a federal district court in Wisconsin held that ...
Read More >
Davidow v. LRN Corp., C.A. No. 2019-0150-MTZ (Del. Ch. Feb. 25, 2020). Delaware law does not invoke ...
Read More >
On July 24, 2019, New York Governor Andrew Cuomo signed legislation creating a statewide panel to st...
Read More >
I don’t believe in coincidence and when something happens twice, it’s a cause for concern. Within ...
Read More >
The Equal Employment Opportunity Commission (EEOC) has issued a set of Frequently Asked Questions (F...
Read More >
World Law Group (WLG) has released the second edition of the WLG Merger Control Guide, which provide...
Read More >